Skip to main content
SpringerLink
Log in
Book cover

Imaging and Intervention in Urinary Tract Infections and Urosepsis pp 127–141Cite as

Nuclear Medicine in the Management of Patient with Kidneys Intracystic Infection

  • Chapter
  • First Online:

  • 1162 Accesses

Abstract

Nuclear medicine plays an important role in the evaluation of inflammatory processes for many years. The tools used, starting from the gamma camera, passing through the SPECT, up to the latest PET scan, have increased diagnostic accuracy in this difficult field. Even the more specific radiotracers that are being used are a goal in further improving the appropriateness of nuclear medicine in this area. Many studies have shown that positron emission tomography with 2-deoxy- 2-[fluorine-18]fluoro-D-glucose integrated with computed tomography (18F-FDG-PET/CT), commonly used in the oncology field, has also the features to study some diseases with inflammatory origin which are usually difficult to identify using traditional diagnostic techniques. Indeed the activated inflammatory cells accumulate FDG with high concentration depending upon the degree of stimulation that is a function of inflammatory activity. In particular some recent papers have suggested that FDG-PET is a very promising tool in the diagnosis of the infected kidney and liver cysts in autosomal dominant polycystic kidney disease (ADPKD). Basing on our large personal experience, we report images of some suggestive clinical cases and the major works written in the literature about this specific clinical setting. At last limits, advantages and potential of this diagnostic examination, together with some new future development, are reported in this chapter.

This is a preview of subscription content, log in via an institution.

References

  1. Jamar F, Buscombe J, Chiti A, Christian PE, Delbeke D, Donohoe KJ, Israel O, Martin-Comin J, Alberto S (2013) EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med 54(4):647–658

    Article  PubMed  Google Scholar 

  2. Bailey DL et al (2005) Positron emission tomography: basic sciences. Springer-Verlag, Secaucus

    Book  Google Scholar 

  3. Boerman OC, Rennen H, Oyen WJ et al (2001) Radiopharmaceuticals to image infection and inflammation. Semin Nucl Med 31:286–295

    Article  CAS  PubMed  Google Scholar 

  4. Love C, Palestro CJ (2004) Radionuclide imaging of infection. J Nucl Med Technol 32:47–57

    PubMed  Google Scholar 

  5. Mirtcheva RM, Kostakoglu SJ, Goldsmith SJ (2003) SPECT/CT fusion imaging in 111In WBC scintigraphy. J Nucl Med 44:341

    Google Scholar 

  6. Becker W, Meller J (2001) The role of nuclear medicine in infection and inflammation. Lancet Infect Dis 1:326–333

    Article  CAS  PubMed  Google Scholar 

  7. Hakki S, Harwood SJ, Morrissey MA et al (1997) Comparative study of monoclonal antibody scan in diagnosing orthopaedic infection. Clin Orthop 335:275–285

    Google Scholar 

  8. Palestro CJ, Kipper SL, Weiland FL et al (2002) Osteomyelitis: diagnosis with (99m)Tc-labeled antigranulocyte antibodies compared with diagnosis with (111)In-labeled leukocytes––initial experience. Radiology 223(3):758–764

    Article  PubMed  Google Scholar 

  9. Horger M, Eschmann SM, Pfannenberg C et al (2003) The value of SPET/CT in chronic osteomyelitis. Eur J Nucl Med Mol Imaging 30(12):1665–1673

    Article  PubMed  Google Scholar 

  10. James ML, Gambhir SS (2012) A molecular imaging primer: modalities, imaging agents, and applications. Physiol Rev 92(2):897–965

    Article  CAS  PubMed  Google Scholar 

  11. Farghaly H, Nasr H, Al Qarni A (2015) Role of FDG PET/CT in infection and inflammation. J Nucl Med 56(supplement 3):1954

    Google Scholar 

  12. Jouret F, Lhommel R, Devuyst O, Annet L, Hassoun Z, Kanaan N (2012) Diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: attributes and limitations of the current modalities. Nephrol Dial Transplant 27(10):3746–3751

    Article  CAS  PubMed  Google Scholar 

  13. Torres VE, Harris PC, Pirson Y (2007) Autosomal dominant polycystic kidney disease. Lancet 369(9569):1287–1301

    Article  PubMed  Google Scholar 

  14. Sallée M, Rafat C, Zahar JR et al (2009) Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 4(7):1183–1189

    Article  PubMed  PubMed Central  Google Scholar 

  15. Christophe JL, van Ypersele de Strihou C, Pirson Y (1996) Complications of autosomal dominant polycystic kidney disease in 50 haemodialysed patients. A case-control study. The U.C.L. collaborative group. Nephrol Dial Transplant 11(7):1271–1276

    Article  CAS  PubMed  Google Scholar 

  16. Jacquet A, Pallet N, Kessler M et al (2011) Outcomes of renal transplantation in patients with autosomal dominant polycystic kidney disease: a nationwide longitudinal study. Transpl Int 24(6):582–587

    Article  PubMed  Google Scholar 

  17. Jouret F, Lhommel R, Beguin C et al (2011) Positron-emission computed tomography in cyst infection diagnosis in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 6(7):1644–1650

    Article  PubMed  Google Scholar 

  18. Piccoli GB, Arena V, Consiglio V et al (2011) Positron emission tomography in the diagnostic pathway for intracystic infection in ADPKD and ‘cystic’ kidneys. A case series. BMC Nephrol 12:48

    Article  PubMed  PubMed Central  Google Scholar 

  19. Telenti A, Torres VE, Gross JB Jr et al (1990) Hepatic cyst infection in autosomal dominant polycystic kidney disease. Mayo Clin Proc 65(7):933–942

    Article  CAS  PubMed  Google Scholar 

  20. Migali G, Annet L, Lonneux M et al (2008) Renal cyst infection in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 23(1):404–405

    Article  PubMed  Google Scholar 

  21. Ichioka K, Saito R, Matsui Y et al (2007) Diffusion-weighted magnetic resonance imaging of infected renal cysts in a patient with polycystic kidney disease. Urology 25(1):1219

    Article  Google Scholar 

  22. Keidar Z, Gurman-Balbir A, Gaitini D et al (2008) Fever of unknown origin: the role of 18F-FDG PET/CT. J Nucl Med 49(12):1980–1985

    Article  PubMed  Google Scholar 

  23. Boellaard R, O’Doherty MJ, Weber WA et al (2010) FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging. Eur J Nucl Med Mol Imaging 42:328–354

    Article  Google Scholar 

  24. Bleeker-Rovers CP, de Sevaux RG, van Hamersvelt HW et al (2003) Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease. Am J Kidney Dis 41(6):E18–E21

    Article  PubMed  Google Scholar 

  25. Bonsib SM (2009) Renal cystic diseases and renal neoplasms: a mini review. Clin J Am Soc Nephrol 4(12):1998–2007

    Article  PubMed  Google Scholar 

  26. Repko BM, Tulchinsky M (2008) Increased F-18 FDG uptake in resolving atraumatic bilateral adrenal hemorrhage (hematoma) on PET/CT. Clin Nucl Med 33(9):651–653

    Article  PubMed  Google Scholar 

  27. Bobot M, Ghez C, Gondouin B, Sallée M, Fournier PE, Burtey S, Legris T, Dussol B, Berland Y, Souteyrand P, Tessonnier L, Cammilleri S, Jourde-Chiche N (2016) Diagnostic performance of [(18)F]fluorodeoxyglucose positron emission tomography-computed tomography in cyst infection in patients with autosomal dominant polycystic kidney disease. Clin Microbiol Infect 22(1):71–77

    Article  CAS  PubMed  Google Scholar 

  28. Bird JL, Izquierdo-Garcia D, Davies JR, Rudd JH, Probst KC, Figg N et al (2010) Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis. Atherosclerosis 210(2):388–391

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Gaemperli O, Shalhoub J, Owen DR, Lamare F, Johansson S, Fouladi N et al (2012) Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography. Eur Heart J 33(15):1902–1910

    Article  CAS  PubMed  Google Scholar 

  30. Hatori A, Yui J, Yamasaki T, Xie L, Kumata K, Fujinaga M et al (2012) PET imaging of lung inflammation with [18F]FEDAC, a radioligand for translocator protein (18 kDa). PLoS One 7(9):e4506

    Article  Google Scholar 

  31. Hannestad J, Gallezot JD, Schafbauer T, Lim K, Kloczynski T, Morris ED et al (2012) Endotoxin-induced systemic inflammation activates microglia:[11C]PBR28 positron emission tomography in nonhuman primates. NeuroImage 63(1):232–239

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Roeda D, Kuhnast B, Damont A, Dollé F (2012) Synthesis of fluorine-18-labelled TSPO ligands for imaging neuroinflammation with positron emission tomography. J Fluor Chem 134:107–114

    Article  CAS  Google Scholar 

  33. Ching AS, Kuhnast B, Damont A, Roeda D, Tavitian B, Dolle F (2012) Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases. Insights Imaging 3(1):111–1119

    Article  PubMed  Google Scholar 

  34. Oh U, Fujita M, Ikonomidou VN, Evangelou IE, Matsuura E, Harberts E et al (2011) Translocator protein PET imaging for glial activation in multiple sclerosis. J Neuroimmune Pharmacol 6(3):354–361

    Article  PubMed  Google Scholar 

  35. Papadopoulos V, Lecanu L (2009) Translocator protein (18 kDa) TSPO: an emerging therapeutic target in neurotrauma. 2009. Exp Neurol 219:53–57

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Pugliese F, Gaemperli O, Kinderlerer AR, Lamare F, Shalhoub J, Davies H et al (2010) Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography/computed tomography angiography. J Am Coll Cardiol 56(8):653–661

    Article  PubMed  Google Scholar 

  37. Lamare F, Hinz R, Gaemperli O, Pugliese F, Mason JC, Spinks T et al (2011) Detection and quantification of large-vessel inflammation with 11C-(R)-PK11195 PET/CT. J Nucl Med 52(1):33–39

    Article  PubMed  Google Scholar 

  38. Hardwick MJ, Chen MK, Baidoo K, Pomper MG, Guilarte TR (2005) In vivo imaging of peripheral benzodiazepine receptors in mouse lungs: a biomarker of inflammation. Mol Imaging 4(4):432–438

    PubMed  Google Scholar 

  39. Xie L, Yui J, Hatori A, Yamasaki T, Kumata K, Wakizaka H et al (2012) Translocator protein (18kDa), a potential molecular imaging biomarker for non-invasively distinguishing non-alcoholic fatty liver disease. J Hepatol 57(5):1076–1082

    Article  CAS  PubMed  Google Scholar 

  40. Horti AG, Gao Y, Ravert HT, Finley P, Valentine H, Wong DF et al (2010) Synthesis and biodistribution of [11C]A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB2). Bioorg Med Chem 18(14):5202–5207

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Locke LW, Chordia MD, Zhang Y, Kundu B, Kennedy D, Landseadel J et al (2009) A novel neutrophil-specific PET imaging agent: cFLFLFK-PEG-64Cu. J Nucl Med 50(5):790–797

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Hawkey CJ (1999) COX-2 inhibitors. Lancet 353(9149):307–314

    Article  CAS  PubMed  Google Scholar 

  43. Katori M, Majima M (2000) Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors. Inflamm Res 49(8):367–392

    Article  CAS  PubMed  Google Scholar 

  44. Minghetti L (2004) Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 63(9):901–910

    Article  CAS  PubMed  Google Scholar 

  45. de Vries EFJ, Doorduin J, Dierckx RA, van Waarde A (2008) Evaluation of [11C]rofecoxib as PET tracer for cyclooxygenase 2 overexpression in rat. Nucl Med Biol 35(1):35–42

    Article  PubMed  Google Scholar 

  46. Uddin MJ, Crews BC, Ghebreselasie K, Huda I, Kingsley PJ, Ansari MS et al (2011) Fluorinated COX-2 inhibitors as agents in PET imaging of inflammation and cancer. Cancer Prev Res (Phila) 4(10):1536–1545

    Article  CAS  Google Scholar 

  47. Wuest F, Kniess T, Bergmann R, Pietzsch J (2008) Synthesis and evaluation in vitro and in vivo of a 11C-labeled cyclooxygenase-2 (COX-2) inhibitor. Bioorg Med Chem 16(16):7662–7670

    Article  CAS  PubMed  Google Scholar 

  48. Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, Wabitsch M et al (2008) T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 28(7):1304–1310

    Article  CAS  PubMed  Google Scholar 

  49. Signore A, Picarelli A, Annovazzi A, Britton KE, Grossman AB, Bonanno E et al (2003) 123I-Interleukin-2: biochemical characterization and in vivo use for imaging autoimmune diseases. Nucl Med Commun 24(3):305–316

    Article  CAS  PubMed  Google Scholar 

  50. Signore A, Chianelli M, Annovazzi A, Rossi M, Maiuri L, Greco M et al (2000) Imaging active lymphocytic infiltration in coeliac disease with iodine-123-interleukin-2 and the response to diet. Eur J Nucl Med 27(1):18–24

    Article  CAS  PubMed  Google Scholar 

  51. Annovazzi A, Bonanno E, Arca M, D’Alessandria C, Marcoccia A, Spagnoli LG et al (2006) 99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques. Eur J Nucl Med Mol Imaging 33(2):117–126

    Article  CAS  PubMed  Google Scholar 

  52. Di Gialleonardo V, Signore A, Glaudemans AW, Dierckx RA, De Vries EF (2012) N-(4-18F-fluorobenzoyl)interleukin-2 for PET of human-activated T lymphocytes. J Nucl Med 53(5):679–686

    Article  PubMed  Google Scholar 

  53. Cairns CB, Panacek EA, Harken AH, Banerjee A (2000) Bench to bedside:tumor necrosis factor-alpha: from inflammation to resuscitation. Acad Emerg Med 7(8):930–941

    Article  CAS  PubMed  Google Scholar 

  54. Maki-Petaja KM, Elkhawad M, Cheriyan J, Joshi FR, Ostor AJ, Hall FC et al (2012) Anti-tumor necrosis factor-alpha therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis. Circulation 126(21):2473–2480

    Article  PubMed  Google Scholar 

  55. Bissonnette R, Tardif JC, Harel F, Pressacco J, Bolduc C, Guertin MC (2013) Effects of the TNF alpha antagonist adalimumab on arterial inflammation assessed by positron emission tomography in patients with psoriasis: results of a randomized controlled trial. Circ Cardiovasc Imaging 6(1):83–90

    Article  PubMed  Google Scholar 

  56. Cao Q, Cai W, Li ZB, Chen K, He L, Li HC et al (2007) PET imaging of acute and chronic inflammation in living mice. Eur J Nucl Med Mol Imaging 34(11):1832–1842

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. PET/CT Center, Affidea IRMET, Torino, Italy

    Daniele Penna, Vincenzo Arena, Angelina Cistaro & Ettore Pelosi

  2. Nuclear Medicine Department, Central Manchester University Hospitals Foundation Trust, Manchester, UK

    Vincenzo Militano

Authors
  1. Daniele Penna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vincenzo Militano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vincenzo Arena
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Angelina Cistaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ettore Pelosi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vincenzo Arena .

Editor information

Editors and Affiliations

  1. Department of Radiology, Luigi Sacco Hospital, Milan, Italy

    Massimo Tonolini

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Penna, D., Militano, V., Arena, V., Cistaro, A., Pelosi, E. (2018). Nuclear Medicine in the Management of Patient with Kidneys Intracystic Infection. In: Tonolini, M. (eds) Imaging and Intervention in Urinary Tract Infections and Urosepsis. Springer, Cham. https://doi.org/10.1007/978-3-319-68276-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-68276-1_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-68275-4

  • Online ISBN: 978-3-319-68276-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation